NEW YORK (AP) _ Fortress Biotech Inc. (FBIO) on Monday reported a loss of $20.8 million in its third quarter.

On a per-share basis, the New York-based company said it had a loss of 26 cents.

The results did not meet Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 8 cents per share.

The biopharmaceutical company posted revenue of $21.1 million in the period, exceeding Street forecasts. Six analysts surveyed by Zacks expected $18.4 million.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FBIO at https://www.zacks.com/ap/FBIO

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News